Myriad Genetics Q2 Profit Soars 57%, Announces Acquisition

Myriad Genetics delivers 37% top-line growth and boosts its full-year forecast after announcing the acquisition of Crescendo Bioscience.

Feb 4, 2014 at 6:02PM

Following a number of tumultuous months, shareholders of molecular diagnostics company Myriad Genetics (NASDAQ:MYGN) have a reason to smile after the company delivered impressive second-quarter earnings results after the bell.

For the quarter, Myriad Genetics reported a 37% increase in revenue to $204.1 million as adjusted EPS increased a whopping 57% to $0.66.

Molecular diagnostics growth accounted for the bulk of Myriad's gains, with its oncology segment seeing sales increase 12% to $101.6 million and its women's health revenue soaring 90% to $94.6 million.

The company's BRACAnalysis test, a genetic test targeting the BRCA1 and BRCA 2 genes which are associated with a higher risk of breast and ovarian cancer, saw sales increase 28% to $141.2 million, and represented 69% of total company revenue. Similarly, the company's BART diagnostic also saw revenue rise 57% to $24.7 million.

Another bright spot for Myriad was the recent launch of its myRisk Hereditary Cancer Test which launch in September and brought in $11.5 million in revenue for the quarter.

Also after the bell, Myriad announced the acquisition of privately held Crescendo Bioscience for $270 million in cash (which will be reduced by $25 million for the repayment of a loan made to Crescendo). Crescendo's diagnostics portfolio and focus on the rheumatoid arthritis market will "enable us to move to the next level in terms of scale and growth," according to William Hagstrom, CEO of Crescendo Bioscience.

Looking ahead, and factoring in its acquisition of Crescendo, Myriad Genetics boosted its full-year 2014 revenue and EPS guidance to a new range of $740 million to $750 million and $2.09-$2.12 from its own prior forecast of $700 million to $715 million and $1.92-$1.97.

Sean Williams has no material interest in any companies mentioned in this article. You can follow him on CAPS under the screen name TMFUltraLong, track every pick he makes under the screen name TrackUltraLong, and check him out on Twitter, where he goes by the handle @TMFUltraLong.

Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Money to your ears - A great FREE investing resource for you

The best way to get your regular dose of market and money insights is our suite of free podcasts ... what we like to think of as “binge-worthy finance.”

Feb 1, 2016 at 5:03PM

Whether we're in the midst of earnings season or riding out the market's lulls, you want to know the best strategies for your money.

And you'll want to go beyond the hype of screaming TV personalities, fear-mongering ads, and "analysis" from people who might have your email address ... but no track record of success.

In short, you want a voice of reason you can count on.

A 2015 Business Insider article titled, "11 websites to bookmark if you want to get rich," rated The Motley Fool as the #1 place online to get smarter about investing.

And one of the easiest, most enjoyable, most valuable ways to get your regular dose of market and money insights is our suite of free podcasts ... what we like to think of as "binge-worthy finance."

Whether you make it part of your daily commute or you save up and listen to a handful of episodes for your 50-mile bike rides or long soaks in a bubble bath (or both!), the podcasts make sense of your money.

And unlike so many who want to make the subjects of personal finance and investing complicated and scary, our podcasts are clear, insightful, and (yes, it's true) fun.

Our free suite of podcasts

Motley Fool Money features a team of our analysts discussing the week's top business and investing stories, interviews, and an inside look at the stocks on our radar. The show is also heard weekly on dozens of radio stations across the country.

The hosts of Motley Fool Answers challenge the conventional wisdom on life's biggest financial issues to reveal what you really need to know to make smart money moves.

David Gardner, co-founder of The Motley Fool, is among the most respected and trusted sources on investing. And he's the host of Rule Breaker Investing, in which he shares his insights into today's most innovative and disruptive companies ... and how to profit from them.

Market Foolery is our daily look at stocks in the news, as well as the top business and investing stories.

And Industry Focus offers a deeper dive into a specific industry and the stories making headlines. Healthcare, technology, energy, consumer goods, and other industries take turns in the spotlight.

They're all informative, entertaining, and eminently listenable. Rule Breaker Investing and Answers are timeless, so it's worth going back to and listening from the very start; the other three are focused more on today's events, so listen to the most recent first.

All are available for free at www.fool.com/podcasts.

If you're looking for a friendly voice ... with great advice on how to make the most of your money ... from a business with a lengthy track record of success ... in clear, compelling language ... I encourage you to give a listen to our free podcasts.

Head to www.fool.com/podcasts, give them a spin, and you can subscribe there (at iTunes, Stitcher, or our other partners) if you want to receive them regularly.

It's money to your ears.

 


Compare Brokers